Over the past few months, we've been featuring videos from the folks at Mutual of Omaha, which in turn feature some of that carrier's senior Long Term Care insurance underwriters. They're an opportunity to peek "under the hood" at how carriers assess and price risk.
In this final installment, MoO's Director of Underwriting, Allen Gregoire, "discusses the effort his LTC underwriting team puts into quick turnarounds, and wonders how the future of insurance underwriting, especially concerning genetic testing and cognitive diagnoses like Alzheimer's and dementia."
We've touched on genetic testing before, and all I can say is that we'd better be aware of just how insidious its inclusion in the underwriting process would be.
Here's Allen:
In this final installment, MoO's Director of Underwriting, Allen Gregoire, "discusses the effort his LTC underwriting team puts into quick turnarounds, and wonders how the future of insurance underwriting, especially concerning genetic testing and cognitive diagnoses like Alzheimer's and dementia."
We've touched on genetic testing before, and all I can say is that we'd better be aware of just how insidious its inclusion in the underwriting process would be.
Here's Allen:
Posts
